Published date: 2 February 2021
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Vaccines - 33651600
Location of contract
United Kingdom, Channel Islands, Isle of Man
Value of contract
£0
Procurement reference
CF-0107300D0O000000rwimUAA1
Published date
2 February 2021
Closing date
14 August 2020
Closing time
12am
Contract start date
1 March 2021
Contract end date
28 February 2025
Contract type
Supply contract
Procedure type
Negotiated procedure without prior publication (above threshold)
The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The provision of pneumococcal polysaccharide vaccine, deliveries will be required from 1 March 2021 to 28 February 2025
Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier.
More information
Links
-
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kFtr/LcibxoyCCaTb2OJBf3fLsPF6iLIhda3cLtuwZ0YhAfM
- Contract_CM_PHV_20_1505_PPV23_Redacted_1
Award information
Awarded date
26 January 2021
Contract start date
1 March 2021
Contract end date
28 February 2025
Total value of contract
£0
This contract was awarded to 1 supplier.
Merck Sharpe & Dohme (UK) Limited
Address
120 Moorgate,
London, United Kingdom EC2M 6URReference
None
Supplier is SME?
No
Supplier is VCSE?
No
About the buyer
Contact name
Lynne Nichols
Address
2nd Floor, Rutland House
Runcorn
WA7 2ES
GB
Share this notice
Closing: 14 August 2020, 12am